Regeneron signs drug pricing deal with Trump, will offer free hearing loss therapy
Regeneron He agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump,…
Biotechnology
Regeneron weighs overseas pricing of gene therapy for rare hearing loss
Regeneron Pharmaceuticals will make its recently approved gene therapy for a rare genetic form of hearing loss available for free…
RFK Jr. says he would support a possible ban on junk food TV ads
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. gestures as he speaks during an event in the…
Trump nominates Erica Schwartz as CDC director
Rear Admiral Erica G. Schwartz. US Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz…
Novo Nordisk partners with OpenAI as hopes rise for AI drug discovery
Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
Novo Nordisk launches Wegovy subscription for GLP-1 anti-obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images Nordisk on Tuesday launched a multi-month subscription program…
Eli Lilly's obesity drug retatrutide passes late-stage diabetes trial
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. He wanted my help to build a platform on CNBC…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…